Narrow search
Showing 1 - 10 of 23,000
Cover Image
Promoting vaccinations - an analysis of measures taken by German statutory health insurers
Damm, Kathrin; Schubert, Jana M.; Schulenburg, … - In: Health economics review 1 (2011) 16, pp. 1-6
but also those who have not been vaccinated. In order to achieve this, a high vaccination rate is necessary; for many … vaccinations was upgraded in 2007 within the scope of the reform of the health system. The reimbursement of patients' vaccination … evaluate to what extent the health insurance companies promote the increasing of vaccination coverage rate today and what …
Persistent link: https://www.econbiz.de/10009503925
Cover Image
Public health impact and cost-effectiveness of intranasal live attenuated influenza vaccination of children in Germany
Damm, Oliver; Eichner, Martin; Rose, Markus Andreas; … - In: The European journal of health economics : HEPAC ; … 16 (2015) 5, pp. 471-488
Persistent link: https://www.econbiz.de/10011299236
Cover Image
Regulierung präventiver Leistungen am Beispiel der Masernschutzimpfungen und Brustkrebsfrüherkennung
Schneider, Markus - In: Wettbewerb und Regulierung im Gesundheitswesen : …, (pp. 139-159). 2004
Persistent link: https://www.econbiz.de/10002401358
Cover Image
What determines COVID-19 vaccination rates in Germany?
Ambros, Maximilian; Frenkel, Michael - In: Jahrbücher für Nationalökonomie und Statistik 242 (2022) 1, pp. 149-157
Persistent link: https://www.econbiz.de/10013162103
Cover Image
The strategic use of nudging and behavioural approaches in public health policy during the coronavirus crisis
Michalek, Gabriela; Schwarze, Reimund - 2020
Nudging and behavioural insights need to be taken into account in strategic action planning for suppression and reduction of pandemic effects. This paper focuses on a few selected areas of significant importance to getting SAR-CoV2 under control in both the nonpharmaceutical and the...
Persistent link: https://www.econbiz.de/10012254413
Cover Image
Comment on "Modeling the cost-effectiveness of infant vaccination with pneumococcal conjugate vaccines in Germany"
Gandjour, Afschin - In: The European journal of health economics : HEPAC ; … 19 (2018) 3, pp. 471-472
Persistent link: https://www.econbiz.de/10011952176
Cover Image
Authors' reply to Gandjour: "Modeling the cost-effectiveness of infant vaccination with pneumococcal conjugate vaccines in Germany"
Kuhlmann, Alexander; Schulenburg, Johann-Matthias von der - In: The European journal of health economics : HEPAC ; … 19 (2018) 3, pp. 473-481
Persistent link: https://www.econbiz.de/10011952179
Cover Image
Modeling the cost-effectiveness of infant vaccination with pneumococcal conjugate vaccines in Germany
Kuhlmann, Alexander; Schulenburg, Johann-Matthias von der - In: The European journal of health economics : HEPAC ; … 18 (2017) 3, pp. 273-292
Persistent link: https://www.econbiz.de/10011868215
Cover Image
Why do COVID-19 fatality rates differ across countries? an explorative cross-country study based on select indicators
Banik, Arindam; Nag, Tirthankar; Roy Chowdhury, Sahana; … - In: Global business review 21 (2020) 3, pp. 607-625
Persistent link: https://www.econbiz.de/10012259319